Acrylamide and Health Outcomes

NCT06224725 · clinicaltrials.gov ↗

COMPLETED

Status

1700

Enrollment

OTHER

Sponsor class

Conditions

Dementia
Dementia Alzheimers
Parkinson Disease
Myocardial Infarction

Interventions

OTHER: dietary acrylamide exposure measured via biomarkers in blood (hemoglobin adducts of acrylamide and glycidamide)

Sponsor

Karolinska Institutet

Collaborators

[object Object]